Article

Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review

2020-08-06

Abstract excerpt

<h4>Purpose</h4> Any available evidence regarding the application of local consolidative therapy (LCT) for oligometastases is from phase 2 and observational studies. This study aimed to evaluate the oncologic benefits of LCT in oligometastatic setting. <h4>Methods</h4> The MEDLINE, EMBASE, and Cochrane library were searched. We applied stepwise analyses that enabled the evaluation of data from randomized controlle...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3775c630-5713-547a-92f5-e4426729cb91
DOI: 10.1101/2020.08.05.20168724

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic reviewDOI 10.1101/2020.08.05.20168724Read

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment.Semantic proximity Read

Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.Semantic proximity Read

Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase Inhibitors.Semantic proximity Read

EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastasesSemantic proximity Read

A Single Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally-Advanced Non-small Cell Lung Cancer (NSCLC)Semantic proximity Read

Clinical outcome of node-negative oligometastatic non-small cell lung cancer.Semantic proximity Read

[Definitions of oligometastatic disease and new treatment concepts].Semantic proximity Read

Subgroup-Level Network Meta-Analysis for the Efficacy of First-Line Immunotherapy-Based Treatments in Advanced Non-Small Cell Lung CancerSemantic proximity Read

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.Semantic proximity Read

The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope.Semantic proximity Read

Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer.Semantic proximity Read

Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancer.Semantic proximity Read